Making Drugs, Shaping the Rules
Article Abstract:
The pharmaceutical industry is under increasing federal scrutiny for using various methods to influence state governments to buy its schizophrenia drugs for mental hospitals, mental health clinics and Medicaid programs. Drug companies helped Texas create guidelines to urge favoritism towards newer drugs like Risperdal, Zyprexa and Seroquel which are more expensive than the popular but cheaper anti-psychotic Haldol. While these medications do not have the market value of popular drugs, such as Viagra, Celebrex and Vioxx, they generated $6.5 billion in 2003 sales. The pharmaceutical companies maintain that their efforts to influence guidelines are aimed only at making sure patients get the best treatment.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Breastfeeding Ads Delayed By a Dispute Over Content
Article Abstract:
Dept. of Health and Human Services has delayed a public service ad campaign on breast feeding until it gets additional information from the American Academy of Pediatricians and manufacturers of infant formula. The Ad Council, which is designing the campaign, stated in its newsletter that there was disagreement over the extent of the emphasis on health risks to babies who are not breast fed. Pediatricians are divided on the impact of infant formula on later development of leukemia, diabetes and other diseases. They are concerned about the scientific foundation of these health claims and feel it is appropriate for HHS to modify the public service ad content.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Campaign for Medical Device Bypasses Doctors
Article Abstract:
The Stryker Corp. and Zimmer Holdings Inc. are conducting major national advertising campaigns to convince potential consumers to choose their hip-replacement devices. This ad campaign strategy puts greater focus on marketing directly more to patients than to doctors who might recommend their devices. It is a controversial strategy because patient advocates are concerned about the limited information that is available through advertisements. Both companies offer Web sites that provide additional information.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Doing the casanova. A roast by any other name. The truth drug
- Abstracts: Eruptions of doom spew steadily from the gold bugs. Wheeling and dealing in tech land, with nary a bubble in sight
- Abstracts: For Mighty Gillette, These Are the Faces of War. Cosmetics Break the Skin Barrier. Statistics and Emotions Clash in Corporate Bias Cases
- Abstracts: Fight Against Fat Shifting to the Workplace. Tired of TiVo? Beyond Blogs? Podcasts Are Here. A 21st-Birthday Drinking Game Can Be a Deadly Rite of Passage
- Abstracts: CIBC seeks new agency in year of ad industry upheaval. Publicis poised to hire new president